The paper reviews early 1920s–30s clinical trials and the pharmacology of Banisteriopsis caapi and its harmala alkaloids (notably harmine), and argues that—despite historical abandonment—harmine merits reevaluation as a potential rapidly acting anti‑Parkinsonian agent.
- Published
- Journal
- Movement Disorders Clinical Practice
- Authors
- Bernschneider‐Reif, S., Poewe, W., Lees, A.